Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

Background: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This study assessed the efficacy and safety of tofacitinib in Chinese patients with RA enrolled in Phase 3 and long-term extension (LTE) studies. Methods: ORAL Sync was a 1-year, randomized, pla...

Full description

Bibliographic Details
Main Authors: Zhan-Guo Li, Yi Liu, Hu-Ji Xu, Zhi-Wei Chen, Chun-De Bao, Jie-Ruo Gu, Dong-Bao Zhao, Yuan An, Lie-Ju Hwang, Lisy Wang, Joel Kremer, Qi-Zhe Wu
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Chinese Medical Journal
Subjects:
Clinical Efficacy; Patient-Reported Outcomes; Rheumatoid Arthritis; Safety; Tofacitinib
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2683;epage=2692;aulast=Li

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2018;volume=131;issue=22;spage=2683;epage=2692;aulast=Li

Similar Items